Vyndamax ( Tafamidis )

ABOUT VYNDAMAX

ABOUT VYNDAMAX specific resolution  Banner image
ABOUT VYNDAMAX Desktop Banner image
ABOUT VYNDAMAX Mobile Banner image
Next block Q image
Next block A image

VYNDAMAX is a transthyretin stabilizer approved to reduce death and hospitalizations related to heart problems in adults with ATTR-CM.

The clinical studies of VYNDAQEL® (tafamidis meglumine) supported the approval of VYNDAMAX.

VYNDAQEL is currently available as four 20-mg capsules, taken once a day. VYNDAMAX 61 mg is a once-daily, one-capsule form of VYNDAQEL that was developed for patient convenience.

In a study, VYNDAMAX 61 mg was shown to work the same way as VYNDAQEL 80 mg.

LIVE LONGER. IT’S POSSIBLE.

In a clinical trial, VYNDAMAX was proven to significantly reduce death and the number of heart-related hospitalizations in patients with ATTR-CM.

After 30 months, the survival rate was higher in the VYNDAMAX group than in the placebo group. VYNDAMAX was also proven to lower the risk of heart-related hospitalizations by 32% compared with placebo.

People taking VYNDAMAX also saw better results versus those on placebo in measures of quality of life including physical abilities and social activities. These quality-of-life results were noticed in as little as 6 months, and remained consistent throughout the 30-month study.

71%

VYNDAMAX

57%

PLACEBO

Survival Rate
After 30 Months
vfbrgfrtb
arrow text
dcfv
Molecular mobile gif image

HOW VYNDAMAX HELPS FIGHT ATTR-CM

VYNDAMAX binds to the transthyretin protein that causes ATTR-CM, slowing its breakdown and the buildup of dangerous deposits. By doing so, VYNDAMAX can slow the progression of the disease. It must be taken every day, as prescribed, to increase your chances of staying out of the hospital and living longer.

24 image
capsule image
swallowing image

EASY-TO-TAKE VYNDAMAX IS THE FIRST AND ONLY ONCE-DAILY, ONE-CAPSULE TREATMENTFOR ATTR-CM

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
What is VYNDAMAX?
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
What is VYNDAMAX?
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.